79
Participants
Start Date
July 27, 2016
Primary Completion Date
July 28, 2017
Study Completion Date
July 28, 2017
SOF/VEL
400/100 mg tablet administered orally once daily
Hospital Clínic de Barcelona, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Reina Sofía University Hospital, Córdoba
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Ramón Y Cajal, Madrid
Hospital Universitario Virgen del Rocío, Seville
La Fe Hospital, Valencia
Hospital Clinico Zaragoza, Zaragoza
Universität Bern, Bern
University Hospital Zurich, Zurich
Cambridge University Hospitals NHS Foundation Trust, Cambridge
Royal Infirmary of Edinburgh, Edinburgh
St James University Hospital, Leeds
Kings College Hospital, London
Royal Free Hampstead NHS Trust, London
Lead Sponsor
Gilead Sciences
INDUSTRY